





Case ReportMalignant Uterine Perivascular Epithelioid
Cell Tumor: A Case ReportDina J. Chamsy,1 Scott C. Purinton,1 Kelley S. Carrick,2 Debra L. Richardson1
ioid tIntroduction
Perivascular epithelioid cell tumors (PEComas) are mesenchymal
neoplasms that comprise angiomyolipoma, lymphangioleiomyoma-
tosis, clear cell “sugar” tumor of the lung, and similar tumors arising
in visceral sites, bones, and soft tissues termed PEComas not other-
wise specified (PEComas-NOS). Many are related to the inherited
syndrome of tuberous sclerosis complex (TSC), which is caused by
mutations in either of 2 tumor suppressor genes,TSC1 orTSC2, and
an manifest with a variety of neoplasms in different organs, such as the
idneys, heart, eyes, lungs, and skin. PEComas-NOS are rare, with
round 100 cases reported in the English literature.1 Although 40 cases
were described within the uterus, there were only 15 uterine PEComas
that exhibited malignant behavior.2 This report describes a rare case of
alignant uterine PEComa arising within the myometrium.
Case Report
A 46-year-old woman presented with menorrhagia and pelvic pain.
Pelvic examination and the ultrasonogram were consistent with a 14-
week fibroid uterus. Papanicolaou smear and endometrial biopsy results
were negative for malignancy. The patient was initially given leuprolide
acetate. She presented 2 months later with worsening pelvic pain. The
ultrasonogram showed an increase in the size of the largest fibroid from
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Clinical Pra
● Perivascular epithelioid cell tumors (PEComas) are mesen-
chymal neoplasms composed of perivascular epithelioid
cells that coexpress myoid and melanocytic markers.
● They can arise in virtually any anatomic site.
● We describe the case of a 46-year-old woman with a
malignant uterine PEComa.
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http://dx.doi.org/10.1016/j.cogc.2012.05.0027.3 to 9.2 cm (Figure 1). She underwent a total abdominal hysterectomy
with bilateral salpingo-oophorectomy.
Gross pathologic examination of the uterus demonstrated a
9.0-cm circumscribed, solid yellow-brown intramural mass filling
the uterine cavity. Microscopic examination demonstrated a mesen-
chymal neoplasm composed of pleomorphic epithelioid cells with
moderately abundant, lightly eosinophilic to clear cytoplasm; mod-
erate to marked atypia; extensive necrosis; and 4 mitotic figures per
10 high power fields (HPFs) (Figure 2A). Tumor cells were radially
ice Points
● We conclude that surgical staging should be consid-
ered in the setting of all malignant PEComas because
of their unpredictable metastatic potential.
● Adjuvant therapy is still experimental and should be
considered only in case of metastasis.
o. 1, 37-9 © 2012 Elsevier Inc. All rights reserved.
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Figure 1 Uterine Perivascular Epithelioid Cell Tumor (PEComa)
Appearing as a Discrete Mass in the Posterior Wall of the
Uterus Measuring 81  89  92 mm. Mass Distorts the
Serosal and Endometrial Contoursct





















38 Cdistributed around blood vessels and were infiltrating within the
myometrium. Immunostaining showed strong diffuse positivity for
desmin and HMB-45 (Figure 2B, 2C) and multifocal positivity for
caldesmon, Melan-A, and MITF. The tumor was focally positive
for estrogen receptor. Immunostaining for smooth muscle actin
(SMA), S100, and pan keratin were negative. After expert pathologic
review, the final diagnosis was malignant PEComa.
A postoperative computed tomographic scan revealed 2 small soft
tissue masses at the vaginal cuff but no distant metastasis. The patient
underwent repeated exploratory laparotomy and pelvic and paraaor-
tic lymph node dissection. Forty-two lymph node and vaginal cuff
biopsy results were negative for malignancy. The patient had no
Figure 2 (A) Tumor Cells With Round Nuclei and Lightly
Eosinophilic to Clear Cytoplasm (H&E Staining;
Original Magnification 40). (B) Positive
Immunohistochemical Stain for Desmin; Brown
Chromogen (Immunohistochemical Staining;
Original Magnification 20). (C) Positive





Cevidence of disease at her 12-month follow up.
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PEComas-NOS predominantly occurs in women with a mean age
of 54 years at diagnosis. It can occur in almost any organ system;
however the uterus appears to be the most common site. Uterine
PEComas commonly present with vaginal bleeding. They are typi-
cally localized and well circumscribed. They can vary in size and
may have focal areas of hemorrhage and necrosis. Microscopi-
cally, PEComa is composed of spindled and/or epithelioid cells
with lightly eosinophilic to clear cytoplasm, which may be ar-
ranged in sheets, nests, or fascicles and may appear to “spill off”
radially from vascular walls. They generally display slight atypia
and sparse mitotic activity; however a subset can have marked
atypia and elevated mitotic activity.3 PEComas typically express
oth myoid markers (desmin, SMA, caldesmon) and melanocytic
arkers (HMB-45, Melan-A, tyrosinase, and microphthalmia
ranscription factor). Desmin produces positive staining. In the
tudy by Folpe et al4, 33% of cases stained positive for S-100.
olpe4 concluded that HMB-45 was the most sensitive marker for
EComa.
The differential diagnosis of a uterine PEComa includes endome-
rial stromal sarcoma and the much more common true smooth
uscle tumors, with which PEComa shares overlapping gross,
icroscopic, and occasionally immunohistochemical staining
eatures. Diagnosis of this rare entity may be challenging and rests
n the identification of certain histologic features, typically round
o ovoid nuclei and lightly eosinophilic to clear cytoplasm devoid
f paranuclear vacuoles, the coexpression of myoid and melano-
ytic markers, and often the presence of estrogen and progester-
ne receptors and the tumor cells’ focal radial arrangement
round blood vessels.
Most PEComas-NOS follows a benign course; however one third
xhibit locally aggressive behavior and/or metastasis. Our patient
xhibited all the tentative malignancy criteria described by Folpe et
l4 that predict a subsequent aggressive behavior, including tumor
size 5 cm, infiltrative growth pattern, high nuclear grade, necrosis,
and mitotic activity  1/50 HPFs.
Thus far among the limited number of cases reported, no single
criterion or set of criteria has been found to reliably predict the
behavior of this tumor in all cases. PEComas may present with dis-
tant metastasis many years after their initial diagnosis. Fadare2 re-
viewed 40 cases of uterine PEComas, 15 (38%) of which exhibited
malignant behavior. Of these, 7 (47%) had advanced disease at initial
presentation, including 2 patients with lymph node involvement.
The other 8 (53%) patients had disease recurrence to the lung
(2 patients), pelvis (2), pelvis and lymph nodes (1), pelvis, bone and
lung (1), bone and lung (1), and liver and lung (1). The majority of
recurrent cases (87.5%) were clinically confined to the uterus at
initial presentation, as they were diagnosed after a simple hysterec-
tomy and were not surgically staged. This suggests that lymph node
involvement might be diagnosed more often if surgical staging is per-
formed at initial presentation. It is our opinion that until long-term data
on a larger number of patients become available, PEComas-NOS should
be considered tumors of uncertain malignant potential. Thus we
recommend surgical staging of all PEComas that exhibit any of
Folpe’s tentative malignancy criteria.
Dina J. Chamsy et alSurgery is the mainstay of treatment for primary lesions as well as
local and metastatic recurrences. Its aim is to obtain negative surgical
margins. Since most PEComas are benign, primary resection is cu-
rative. The role of adjuvant chemotherapy and radiation therapy in
the management of locally advanced or metastatic disease remains
experimental.
Conclusion
PEComas-NOS are most often benign; however a malignant
course has been documented. Criteria for malignancy are cur-
rently tentative because of the rarity of this diagnosis. Surgical
staging should be considered in patients diagnosed with malig-
nant PEComas. In the setting of a nonmetastatic tumor, resection
alone is the mainstay of treatment. When treating metastatic or localspread, adjuvant chemotherapy and radiation therapy are still exper-
imental and of uncertain benefit.
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